<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName nlm2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Chem</journal-id><journal-id journal-id-type="iso-abbrev">Front Chem</journal-id><journal-id journal-id-type="publisher-id">Front. Chem.</journal-id><journal-title-group><journal-title>Frontiers in Chemistry</journal-title></journal-title-group><issn pub-type="epub">2296-2646</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8987122</article-id><article-id pub-id-type="publisher-id">858708</article-id><article-id pub-id-type="doi">10.3389/fchem.2022.858708</article-id><article-categories><subj-group subj-group-type="heading"><subject>Chemistry</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Genetics Behind the Glycosylation Patterns in the Biosynthesis of Dalbaheptides</article-title><alt-title alt-title-type="left-running-head">Yushchuk et al.</alt-title><alt-title alt-title-type="right-running-head">Glycosylation of Glycopeptide Antibiotics</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yushchuk</surname><given-names>Oleksandr</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/851585/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhukrovska</surname><given-names>Kseniia</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Berini</surname><given-names>Francesca</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/496427/overview"/></contrib><contrib contrib-type="author"><name><surname>Fedorenko</surname><given-names>Victor</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Marinelli</surname><given-names>Flavia</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/319577/overview"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Department of Biotechnology and Life Sciences</institution>, <institution>University of Insubria</institution>, <addr-line>Varese</addr-line>, <country>Italy</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Department of Genetics and Biotechnology</institution>, <institution>Ivan Franko National University of Lviv</institution>, <addr-line>Lviv</addr-line>, <country>Ukraine</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/733810/overview" ext-link-type="uri">Zhongping Tan</ext-link>, Chinese Academy of Medical Sciences and Peking Union Medical College, China</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/319908/overview" ext-link-type="uri">Max Julian Cryle</ext-link>, Monash University, Australia</p></fn><corresp id="c001">*Correspondence: Flavia Marinelli, <email>flavia.marinelli@uninsubria.it</email>
</corresp><fn fn-type="other"><p>This article was submitted to Chemical Biology, a section of the journal Frontiers in Chemistry</p></fn></author-notes><pub-date pub-type="epub"><day>24</day><month>3</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>10</volume><elocation-id>858708</elocation-id><history><date date-type="received"><day>20</day><month>1</month><year>2022</year></date><date date-type="accepted"><day>21</day><month>2</month><year>2022</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2022 Yushchuk, Zhukrovska, Berini, Fedorenko and Marinelli.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Yushchuk, Zhukrovska, Berini, Fedorenko and Marinelli</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Glycopeptide antibiotics are valuable natural metabolites endowed with different pharmacological properties, among them are dalbaheptides used to treat different infections caused by multidrug-resistant Gram-positive pathogens. Dalbaheptides are produced by soil-dwelling high G-C Gram-positive actinobacteria. Their biosynthetic pathways are encoded within large biosynthetic gene clusters. A non-ribosomally synthesized heptapeptide aglycone is the common scaffold for all dalbaheptides. Different enzymatic tailoring steps, including glycosylation, are further involved in decorating it. Glycosylation of dalbaheptides is a crucial step, conferring them specific biological activities. It is achieved by a plethora of glycosyltransferases, encoded within the corresponding biosynthetic gene clusters, able to install different sugar residues. These sugars might originate from the primary metabolism, or, alternatively, their biosynthesis might be encoded within the biosynthetic gene clusters. Already installed monosaccharides might be further enzymatically modified or work as substrates for additional glycosylation. In the current minireview, we cover recent updates concerning the genetics and enzymology behind the glycosylation of dalbaheptides, building a detailed and consecutive picture of this process and of its biological evolution. A thorough understanding of how glycosyltransferases function in dalbaheptide biosynthesis might open new ways to use them in chemo-enzymatic synthesis and/or in combinatorial biosynthesis for building novel glycosylated antibiotics.</p></abstract><kwd-group><kwd>glycopeptide antibiotics</kwd><kwd>dalbaheptides</kwd><kwd>ramoplanin</kwd><kwd>teicoplanin</kwd><kwd>A40926</kwd><kwd>glycosyltransferase</kwd><kwd>biosynthetic gene cluster</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Among different bacterial phyla, the mycelia-forming members of actinobacteria<italic>&#x02010;</italic>broadly known as actinomycetes&#x02010;remain the best antibiotic providers (<xref rid="B7" ref-type="bibr">B&#x000e9;rdy, 2005</xref>; <xref rid="B23" ref-type="bibr">Hutchings et al., 2019</xref>). The biosynthesis of antibiotics involves many enzymes, which are encoded by co-localized genes&#x02010;biosynthetic gene clusters (BGCs) (<xref rid="B38" ref-type="bibr">Medema et al., 2015</xref>). BGCs undergo modular evolution, often exchanging operons and single genes coding for biosynthetic and modification enzymes (<xref rid="B39" ref-type="bibr">Medema et al., 2014</xref>). Genes for glycosyltransferases (GTs) are one such example, being found in different BGCs, with corresponding proteins having relaxed substrate specificity and consequently being able to modify different natural scaffolds (<xref rid="B48" ref-type="bibr">Salas and M&#x000e9;ndez, 2007</xref>).</p><p>The astonishing variability of glycosylation patterns in one group of antibiotics led to their eponymous description as glycopeptide antibiotics (GPAs, <xref rid="B44" ref-type="bibr">Nicolaou et al., 1999</xref>). Natural GPAs amalgamate five types of related compounds, differing in chemical structures, where, paradoxically, only types I-IV&#x02010;also known as dalbaheptides (<xref rid="B45" ref-type="bibr">Parenti and Cavalleri, 1989</xref>)&#x02010;are glycosylated (<xref rid="B44" ref-type="bibr">Nicolaou et al., 1999</xref>). All dalbaheptides possess a non-ribosomal heptapeptide aglycone differing in amino acid (aa) composition, cross-linking, and decoration (<xref rid="B44" ref-type="bibr">Nicolaou et al., 1999</xref>); they inhibit the growth of Gram-positive bacteria by blocking cell wall maturation (<xref rid="B8" ref-type="bibr">Binda et al., 2014</xref>; <xref rid="B68" ref-type="bibr">Yushchuk et al., 2020a</xref>). Glycosylation and acylation (a step depending on glycosylation) of dalbaheptides contribute to their antimicrobial activities, favoring dimerization and membrane localization at the site of action (<xref rid="B19" ref-type="bibr">Gerhard et al., 1993</xref>; <xref rid="B34" ref-type="bibr">Mackay et al., 1994</xref>; <xref rid="B6" ref-type="bibr">Beauregard et al., 1995</xref>; <xref rid="B50" ref-type="bibr">Snyder et al., 1998</xref>). On the other hand, excessive glycosylation does not always bring pharmacological benefits: it seemed to induce platelet aggregation in patients treated with ristocetin (<xref rid="B21" ref-type="bibr">Howard and Firkin, 1971</xref>; <xref rid="B14" ref-type="bibr">Coller and Gralnick, 1977</xref>), which was consequently withdrawn from the clinical use (<xref rid="B18" ref-type="bibr">Gangarosa et al., 1958</xref>).</p><p>Dalbaheptides are clinically used as drugs of last resort against multidrug-resistant Gram-positive pathogens (<xref rid="B36" ref-type="bibr">Marcone et al., 2018</xref>). First-generation GPAs&#x02010;vancomycin and teicoplanin (produced by different <italic>Amycolatopsis</italic> spp. and <italic>Actinoplanes teichomyceticus</italic> ATCC 31121, respectively)&#x02010;have a long and reliable history of clinical application (<xref rid="B24" ref-type="bibr">Jovetic et al., 2010</xref>; <xref rid="B8" ref-type="bibr">Binda et al., 2014</xref>; <xref rid="B36" ref-type="bibr">Marcone et al., 2018</xref>). In turn, natural GPAs served as precursors for three second-generation semisynthetic and clinically used GPAs (<xref rid="B8" ref-type="bibr">Binda et al., 2014</xref>; <xref rid="B9" ref-type="bibr">Butler et al., 2014</xref>): dalbavancin derived from A40926 (produced by <italic>Nonomuraea gerenzanensis</italic> ATCC 39727) (<xref rid="B15" ref-type="bibr">Crotty et al., 2016</xref>), telavancin from chloroeremomycin (from <italic>Kibdelosporangium aridum</italic> A82846) (<xref rid="B26" ref-type="bibr">Klinker and Borgert, 2015</xref>), and oritavancin from vancomycin (<xref rid="B15" ref-type="bibr">Crotty et al., 2016</xref>).</p><p>Although the chemical variety of glycosyl groups decorating dalbaheptide aglycones is quite remarkable (<xref rid="B44" ref-type="bibr">Nicolaou et al., 1999</xref>), many aspects of the genetics behind their biosynthesis and incorporation remain obscure. In this minireview, we focus on those dalbaheptides whose BGC sequences are nowadays available, and for which some experimental evidence about their glycosylation steps is reported in the literature. The model BGCs are <italic>cep</italic>, <italic>bal</italic>, <italic>tei</italic>, <italic>vcm</italic>, and <italic>dbv</italic>, responsible for the production of chloroeremomycin (in <italic>K. aridum</italic> A82846) (<xref rid="B60" ref-type="bibr">van Wageningen et al., 1998</xref>), balhimycin (in <italic>Amycolatopsis balhimycina</italic> DSM 5908) (<xref rid="B49" ref-type="bibr">Shawky et al., 2007</xref>), teicoplanin (<xref rid="B29" ref-type="bibr">Li et al., 2004</xref>), vancomycin (in <italic>Amycolatopsis orientalis</italic> HCCB10007) (<xref rid="B64" ref-type="bibr">Xu et al., 2014</xref>), and A40926 (<xref rid="B52" ref-type="bibr">Sosio et al., 2003</xref>), respectively. BGC from <italic>Amycolatopsis</italic> sp. MJM2582 (<xref rid="B58" ref-type="bibr">Truman et al., 2014</xref>) represents the ristocetin biosynthetic pathway and was found also in other <italic>Amycolatopsis</italic> spp. (<xref rid="B53" ref-type="bibr">Spohn et al., 2014</xref>; <xref rid="B31" ref-type="bibr">Liu et al., 2021</xref>). Glycosylation-related genes from more recently described BGCs for UK-68,597 (<italic>auk</italic> from <italic>Actinoplanes</italic> sp. ATCC 53533) (<xref rid="B65" ref-type="bibr">Yim et al., 2014a</xref>), pekiskomycin (<italic>pek</italic> from <italic>Streptomyces</italic> sp. WAC1420) (<xref rid="B55" ref-type="bibr">Thaker et al., 2013</xref>), keratinimicin (ker from <italic>Amycolatopsis keratiniphila</italic> NRRL B-24117) (<xref rid="B63" ref-type="bibr">Xu et al., 2019</xref>), and A50926 (from <italic>Nonomuraea coxensis</italic> DSM 45129) (<xref rid="B72" ref-type="bibr">Yushchuk et al., 2021</xref>) are also reviewed. Overall, multiple recent findings on dalbaheptide glycosylation updated the overall picture and merit a proper review, outlining what is known and why it is still worthy of further investigations.</p><sec id="s1-1"><title>Delineating Steps in Dalbaheptide Glycosylation</title><p>The biosynthesis of dalbaheptides is generally divided into three distinct stages (<xref rid="B66" ref-type="bibr">Yim et al., 2014b</xref>, <xref rid="B67" ref-type="bibr">2016</xref>; <xref rid="B71" ref-type="bibr">Yushchuk et al., 2020b</xref>), that is, 1) generation of non-proteinogenic aa pool, further utilized in 2) non-ribosomal biosynthesis of the oligopeptide aglycones (coupled with the oxidative cross-linking); fully cross-linked aglycones are further 3) modified in a variety of tailoring steps. All dalbaheptide BGCs encode GTs, tailoring enzymes significantly contributing to the structural variety of these antibiotics (<xref rid="B44" ref-type="bibr">Nicolaou et al., 1999</xref>). Non-glycosylated dalbaheptide A47934 (from <italic>Streptomyces toyocaensis</italic> NRRL 15009) is the only exception here; consistently, the corresponding BGC lacks GT genes (<xref rid="B47" ref-type="bibr">Pootoolal et al., 2002</xref>).</p><p>More in detail, different steps might be defined in the glycosylation process of dalbaheptides, layer by layer &#x0201c;wrapping&#x0201d; the aglycone. The first step includes the biosynthesis of non-conventional sugar donors for aglycone decoration. Indeed, while some dalbaheptides are decorated with sugars deriving from primary metabolism (e.g., <italic>&#x003b1;</italic>-<sc>d</sc>-mannose and <italic>N</italic>-acetylglucosamine (Glc<italic>N</italic>Ac) in teicoplanin or A40926), aglycones of vancomycin, balhimycin, and chloroeremomycin are decorated with the non-conventional monosaccharides <sc>l-</sc>vancosamine, <sc>l-4-</sc>oxovancosamine, and <sc>l</sc>-epivancosamine, respectively. In a similar manner to the biosynthesis of non-proteinogenic aa, enzymes required for the biosynthesis of such non-conventional monosaccharides are encoded within dalbaheptide BGCs. The second step (often the last one) consists of <italic>O</italic>-glycosylation of the aromatic aa forming the aglycone. In the third one, the installed sugars might be further modified in minor or major ways (e.g., <italic>&#x003b1;</italic>-<sc>d-</sc>mannose <italic>O</italic>-acetylation and Glc<italic>N</italic>Ac deacetylation in A40926 biosynthesis).</p></sec><sec><title>Biosynthesis of Non-Conventional Monosaccharides was Required for the Glycosylation of Dalbaheptides</title><p>Conventional sugars in GPAs&#x02010;from primary metabolism&#x02010;are <sc>d-</sc>mannose, <sc>d-</sc>glucose, <sc>d-</sc>arabinose, Glc<italic>N</italic>Ac, and <sc>l-</sc>rhamnose. Non-conventional sugar residues include <sc>l-</sc>vancosamine, <sc>l-</sc>epivancosamine, <sc>l-4-</sc>oxovancosamine, <sc>l-</sc>ristosamine, and <sc>l-</sc>actinosamine. In addition to the aforementioned examples, <sc>l</sc>-vancosamine is present in Substitute with UK-68,597, while <sc>l</sc>-ristosamine is characteristic for ristocetin, and <sc>l</sc>-actinosamine for keratinimicin (<xref rid="B63" ref-type="bibr">Xu et al., 2019</xref>).</p><p>Biosynthesis of <sc>l-</sc>epivancosamine was initially studied in chloroeremomycin producer (<xref rid="B60" ref-type="bibr">van Wageningen et al., 1998</xref>). <italic>In vitro</italic> experiments (<xref rid="B12" ref-type="bibr">Chen et al., 2000</xref>; <xref rid="B25" ref-type="bibr">Kirkpatrick et al., 2000</xref>) demonstrated how five enzymes encoded within <italic>cep</italic>&#x02010;namely, EvaA-E&#x02010;transformed dTDP-4-oxo-6-deoxy-<sc>d</sc>-glucose into <sc>l-</sc>epivancosamine (<xref rid="F1" ref-type="fig">Figure 1</xref>). Biosynthetic routes for aminosugars decorating other dalbaheptides were deduced from this model pathway. Initially activated substrate dTDP-4-oxo-6-deoxy-<sc>d</sc>-glucose is commonly derived from <sc>d</sc>-glucose-1-phosphate by the action of non-BGC-encoded enzymes (<xref rid="F1" ref-type="fig">Figure 1</xref>). One notable exception is the UK-68,597 biosynthesis, since <italic>auk</italic> contains a gene for glucose 1-phosphate thymidylylransferase&#x02010;<italic>auk7</italic> (<xref rid="B65" ref-type="bibr">Yim et al., 2014a</xref>)&#x02010;required for the <sc>D</sc>-glucose-1-phosphate activation. The presence of Auk7 likely positively contributes to the pool of <sc>l-</sc>vancosamine precursors in UK-68,597 biosynthesis.</p><fig position="float" id="F1"><label>FIGURE 1</label><caption><p>Enzymes involved in the biosynthesis of non-conventional aminosugars, decorating aglycones of some dalbaheptides. Biosynthetic pathway of <sc>l-</sc>epivancosamine serves as a model, since EvaA-B-C-D-E, coded within <italic>cep</italic>, are the only enzymes that were studied experimentally. Functions of all other enzymes were assigned by <italic>in silico</italic> comparison (<italic>is</italic>); (<italic>abs</italic>) indicates that the corresponding gene is absent from BGCs; (?) indicates that the assigned function is speculative, having no experimentally investigated prototype. Asterisk at DvaE indicates that this protein is mutated. Refer to the main text for more details.</p></caption><graphic xlink:href="fchem-10-858708-g001" position="float"/></fig><p>
<italic>vcm</italic> for vancomycin contains the orthologs of <italic>evaA-E</italic> genes, namely, <italic>vcaA-E</italic> (<xref rid="B64" ref-type="bibr">Xu et al., 2014</xref>) (<xref rid="F1" ref-type="fig">Figure 1</xref>). The two sets of proteins are quite similar, sharing at least 75% of aa sequence identity (aa s.i.) in each pair (<xref rid="B64" ref-type="bibr">Xu et al., 2014</xref>). Nevertheless, minor differences in EvaE and VcaE seem to impact the function, making the first to convert dTDP-<sc>l-</sc>4-oxovancosamine into dTDP-<sc>l-</sc>epivancosamine, while the second yields dTDP-<sc>l-</sc>vancosamine (<xref rid="F1" ref-type="fig">Figure 1</xref>). Instead, <italic>auk</italic> contains the orthologs of only <italic>evaA</italic>, <italic>evaB</italic>, <italic>evaC</italic>, and <italic>evaD</italic> (<italic>auk13</italic>, <italic>auk12</italic>, <italic>auk9</italic>, and <italic>auk8</italic>, respectively) (<xref rid="B65" ref-type="bibr">Yim et al., 2014a</xref>), lacking the ortholog of <italic>evaE</italic>: probably a functional homolog (or analog) of <italic>evaE</italic> resides outside the <italic>auk</italic> borders, finally contributing to <sc>l</sc>-vancosamine production. More understandable is the case of <italic>bal</italic> (<xref rid="B49" ref-type="bibr">Shawky et al., 2007</xref>), where <italic>evaA-E</italic> orthologs are named <italic>dvaA-E</italic>. Here, <italic>evaE</italic> ortholog <italic>dvaE</italic> is truncated, coding only the 99 aa C-terminal part of C4-ketoreductase (<xref rid="B16" ref-type="bibr">Donadio et al., 2005</xref>). Such truncated protein is non-functional, and consequently, the aminosugar biosynthesis terminates at the stage of dTDP-<sc>l</sc>-4-oxovancosamine (<xref rid="F1" ref-type="fig">Figure 1</xref>). Biosynthetic pathways for <sc>l-</sc>ristosamine and <sc>l-</sc>actinosamine, coded within <italic>ris</italic> and <italic>ker</italic>, are more diverged. They both missed the EvaC ortholog (<xref rid="B53" ref-type="bibr">Spohn et al., 2014</xref>; <xref rid="B58" ref-type="bibr">Truman et al., 2014</xref>; <xref rid="B63" ref-type="bibr">Xu et al., 2019</xref>; <xref rid="B31" ref-type="bibr">Liu et al., 2021</xref>), resulting in the lack of a methyl group at the C3 position (<xref rid="F1" ref-type="fig">Figure 1</xref>). Thus, biosynthesis of <sc>l-</sc>ristosamine might be attributed to the orthologs of EvaA, EvaB, EvaD, and EvaE&#x02010;Orf30, Orf32, Orf33, and Orf31, respectively (<xref rid="B58" ref-type="bibr">Truman et al., 2014</xref>). The same protein set is encoded within <italic>ker</italic>&#x02010;KraA-D (<xref rid="B63" ref-type="bibr">Xu et al., 2019</xref>). The major difference between <sc>l-</sc>actinosamine and <sc>l-</sc>ristosamine is <italic>O</italic>-methylation of the C4-position. It is still unknown how this methylation is achieved; however, the annotation of <italic>ker</italic> reveals the presence of a gene coding for an <italic>O-</italic>methyltransferase&#x02010;<italic>kerM</italic> (<xref rid="B63" ref-type="bibr">Xu et al., 2019</xref>)<italic>.</italic> Since the aglycone of keratinimicin lacks any <italic>O</italic>-methylations, it seems plausible that KerM catalyzes the ultimate step of <sc>l-</sc>actinosamine biosynthesis (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p><p>In all cases described above the orthologs of <italic>evaA-E-B-D</italic> are most likely co-expressed, forming one operon, while the orthologs of <italic>evaC</italic> belong to a separate transcriptional unit (<xref rid="B49" ref-type="bibr">Shawky et al., 2007</xref>; <xref rid="B31" ref-type="bibr">Liu et al., 2021</xref>). <italic>auk</italic> is an exception, with <italic>auk8-9</italic> (<italic>evaD-C</italic>) and <italic>auk12-13</italic> (<italic>evaA-B</italic>) probably belonging to different operons (<xref rid="B65" ref-type="bibr">Yim et al., 2014a</xref>).</p></sec><sec id="s1-2"><title>GTs Involved in Dalbaheptide Glycosylation</title><p>All GTs decorating aglycones of dalbaheptides belong to two families, according to the Carbohydrate-Active enZYmes Database (CAZy, <ext-link xlink:href="http://www.cazy.org/" ext-link-type="uri">http://www.cazy.org</ext-link>, <xref rid="B17" ref-type="bibr">Drula et al., 2022</xref>). GTs responsible for the installation of non-conventional aminosugars and conventional <sc>d-</sc>glucose, <sc>d-</sc>arabinose, Glc<italic>N</italic>Ac, and <sc>l-</sc>rhamnose, belong to the GT1 family. These GTs require sugar substrates to be either dTDP- or UDP-activated, and share a unique two-domain structure (the so-called GT-B fold, <xref rid="B28" ref-type="bibr">Lairson et al., 2008</xref>), having C- and N-terminal Rossmann-like domains connected by a flexible linker region (<xref rid="B73" ref-type="bibr">Zhang et al., 2020</xref>). Recognition sites for the donor NDP-activated sugars are located at C-terminal domains (<xref rid="B11" ref-type="bibr">Chang et al., 2011</xref>), while N-terminal domains contain the acceptor binding site for dalbaheptide aglycone (<xref rid="B11" ref-type="bibr">Chang et al., 2011</xref>; <xref rid="B73" ref-type="bibr">Zhang et al., 2020</xref>). GTs of the second&#x02010;GT39&#x02010;family are responsible for the installation of <sc>d-</sc>mannose and require <sc>d</sc>-mannosyl-1-phosphoundecaprenol as a donor substrate. Large hydrophobic GT39-GTs are predicted as membrane-associated, having a GT-C fold with multiple transmembrane helices and intracellular active sites (<xref rid="B28" ref-type="bibr">Lairson et al., 2008</xref>).</p><p>In the aforementioned dalbaheptides, GT1-GTs attach sugar residues preferentially at AA-4 (4-hydroxyphenylglycine, Hpg) and AA-6 (<italic>&#x003b2;</italic>-hydroxytyrosine, Bht) of the aglycone or add additional monosaccharides to already existing mono/di/trisaccharides at AA-4. Fully cross-linked aglycones serve as acceptor substrates for GT1-GTs under physiological conditions, albeit some GT1-GTs were able to recognize partially cross-linked aglycones under certain experimental conditions, for instance, in mutasynthesis approaches (<xref rid="B62" ref-type="bibr">Weist et al., 2004</xref>; <xref rid="B10" ref-type="bibr">Butz et al., 2008</xref>). GT39-GTs attach mannose at AA-7 (3,5-dihydroxyphenylglycine, Dpg). The presence of multiple GTs within one pathway might result in the production of mixtures of related congeners, differing in glycosylation patterns. Dalbaheptides glycosylated at other AA positions were also described (<xref rid="B44" ref-type="bibr">Nicolaou et al., 1999</xref>), indicating that glycosylation might also occur at 1) AA-2 (Bht) and AA-1 (Hpg) in type II aglycone, and 2) AA-1 (Hpg) and AA-3 (Bht) in type III aglycone. Unfortunately, we currently lack any genomic information on the producers of these molecules, which would merit further investigations.</p><p>Type I dalbaheptides chloroeremomycin, balhimycin, and vancomycin served as the first models for experimental investigation of GT functions. Corresponding BGCs encode slightly different sets of GT1-GTs: GtfA, GtfB, and GtfC in <italic>cem</italic>; BgtfA, BgtfB, and BgtfC in <italic>bal</italic>; and GtfD and GtfE in <italic>vcm.</italic> Orthologous GTs GtfA and BgtfA install <sc>l-</sc>epivancosamine and <sc>l-</sc>4-oxovancosamine at AA-6 of chloroeremomycin and balhimycin, respectively. <italic>vcm</italic> does not encode GtfA ortholog, explaining why vancomycin is not glycosylated at AA-6. Peculiarly, this particular difference between vancomycin and chloroeremomycin seems to augment the antimicrobial activity of the latter, implying that <sc>l-</sc>epivancosamine at AA-6 facilitates cell wall binding (<xref rid="B42" ref-type="bibr">Nagarajan, 1993</xref>; <xref rid="B3" ref-type="bibr">Allen et al., 2002</xref>). GtfB, BgtfB, and GtfE are orthologs, glucosylating AA-4 in the biosynthesis of all three antibiotics (<xref rid="F2" ref-type="fig">Figure 2A</xref>, <xref rid="B46" ref-type="bibr">Pelzer et al., 1999</xref>; <xref rid="B33" ref-type="bibr">Losey et al., 2001</xref>; <xref rid="B40" ref-type="bibr">Mulichak et al., 2001</xref>). Then, GtfC and GtfD attach <sc>l-</sc>epivancosamine or <sc>l-</sc>vancosamine to <sc>d-</sc>glucose at AA-4 in the biosynthesis of chloroeremomycin and vancomycin, respectively (<xref rid="F2" ref-type="fig">Figure 2A</xref>, <xref rid="B33" ref-type="bibr">Losey et al., 2001</xref>, <xref rid="B32" ref-type="bibr">2002</xref>; <xref rid="B41" ref-type="bibr">Mulichak et al., 2004</xref>). GtfC, GtfD, and BgtfC are orthologous proteins, but balhimycin lacks a disaccharide at AA-4, which could be found only in balhimycin V (a congener produced in residual amounts) (<xref rid="B46" ref-type="bibr">Pelzer et al., 1999</xref>; <xref rid="B54" ref-type="bibr">Stegmann et al., 2010</xref>). This might be due to the low affinity of BgtfC for the donor substrate&#x02010;<sc>l-4-</sc>oxovancosamine, produced as a consequence of DvaE mutation. More recently described type I dalbaheptide pekiskomycin is only glucosylated at AA-4, coherently with the only 1 GT encoded in <italic>pek</italic>: Pek28, which is a GtfB ortholog (<xref rid="F2" ref-type="fig">Figure 2A</xref>) (<xref rid="B55" ref-type="bibr">Thaker et al., 2013</xref>).</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Glycosylation patterns of type I <bold>(A)</bold>, type II <bold>(B)</bold>, type III <bold>(C)</bold>, and type IV <bold>(D)</bold> dalbaheptides and enzymes involved therein. Refer to the main text for more details. Dalbaheptide aglycones are depicted schematically with cross-links shown in red, and chlorination and sulfation sites are not shown. Aglycone amino acid abbreviations mean following: Leu&#x02010;leucine; Asn&#x02010;asparagine; Ala&#x02010;alanine; Glu&#x02010;glutamine; Phe&#x02010;phenylalanine; Tyr&#x02010;tyrosine; Bht&#x02010;<italic>&#x000df;</italic>-hydroxytyrosine; Dpg&#x02010;3,5-dihydroxyphenylglycine; Hpg&#x02010;4-hydroxyphenylglycine; Hpp&#x02010;4-hydroxyphenypyruvate; Tyr&#x02010;. Glc<italic>N</italic> stated for <italic>N-</italic>glucosamine, GlcNAcyl for N-acylglucosamine. All enzymes, whose functions were assigned by <italic>in silico</italic> comparison are marked with (<italic>is</italic>); (?) indicates that function was assigned <italic>in silico</italic> without experimentally investigated prototype or exact function remains unknown. For fast access to protein sequences mentioned in this figure, use following links: <italic>cep</italic>: GtfA&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/2894167" ext-link-type="uri">PCZA361.19</ext-link>, GtfB&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/2894168" ext-link-type="uri">PCZA361.20</ext-link>, GtfC&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/2894169" ext-link-type="uri">PCZA361.21</ext-link>; <italic>bal</italic>: BgtfA&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAA76551.1" ext-link-type="uri">CAA76551.1</ext-link>, BgtfB&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAA76552.1" ext-link-type="uri">CAA76552.1</ext-link>, BgtfC&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAA76553.1" ext-link-type="uri">CAA76553.1</ext-link>; <italic>vcm</italic>: GtfE&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AGM04075.1" ext-link-type="uri">AGM04075.1</ext-link>, GtfD&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AGM04074.1" ext-link-type="uri">AGM04074.1</ext-link>; <italic>pek</italic>: Pek28&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AGF91763.1" ext-link-type="uri">AGF91763.1</ext-link>, Pek16&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AGF91751.1" ext-link-type="uri">AGF91751.1</ext-link>; <italic>ker</italic>: GtfA<sub>ker</sub>&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AYA22326.1" ext-link-type="uri">AYA22326.1</ext-link>, GtfB<sub>ker</sub>&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AYA22325.1" ext-link-type="uri">AYA22325.1</ext-link>, GtfC<sub>ker</sub>&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AYA22323.1" ext-link-type="uri">AYA22323.1</ext-link>, GtfD<sub>ker</sub>&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AYA22321.1" ext-link-type="uri">AYA22321.1</ext-link>; <italic>ris</italic>: Orf16&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AHF20591.1" ext-link-type="uri">AHF20591.1</ext-link>, Orf17&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AHF20592.1" ext-link-type="uri">AHF20592.1</ext-link>, Orf18&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AHF20593.1" ext-link-type="uri">AHF20593.1</ext-link>, Orf20&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AHF20595.1" ext-link-type="uri">AHF20595.1</ext-link>; Orf22&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AHF20597.1" ext-link-type="uri">AHF20597.1</ext-link>, Orf34&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AHF20609.1" ext-link-type="uri">AHF20609.1</ext-link>; <italic>auk</italic>: Auk10&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AGS77314.1" ext-link-type="uri">AGS77314.1</ext-link>, Auk11&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/AGS77315.1" ext-link-type="uri">AGS77315.1</ext-link>; <italic>tei</italic>: Tei1&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAG15008.1" ext-link-type="uri">CAG15008.1</ext-link>, Tei2*&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAG15014.1" ext-link-type="uri">CAG15014.1</ext-link>, Tei3*&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAG15015.1" ext-link-type="uri">CAG15015.1</ext-link>, Tei10*&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAG15022.1" ext-link-type="uri">CAG15022.1</ext-link>, Tei11*&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAG15023.1" ext-link-type="uri">CAG15023.1</ext-link>; <italic>dbv</italic>: Dbv8&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAD91203.1/" ext-link-type="uri">CAD91203.1</ext-link>, Dbv9&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAD91204.1" ext-link-type="uri">CAD91204.1</ext-link>, Dbv20&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAD91215.1" ext-link-type="uri">CAD91215.1</ext-link>, Dbv21&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAD91216.1" ext-link-type="uri">CAD91216.1</ext-link>, Dbv23&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAD91218.1" ext-link-type="uri">CAD91218.1</ext-link>, Dbv29&#x02010;<ext-link xlink:href="https://www.ncbi.nlm.nih.gov/protein/CAD91224.1" ext-link-type="uri">CAD91224.1</ext-link>.</p></caption><graphic xlink:href="fchem-10-858708-g002" position="float"/></fig><p>So far, little is known about GTs decorating aglycones of type II dalbaheptides. <italic>ker</italic> (single type II BGC sequenced) carries three genes for GT1-GTs and one gene for GT39-GT (<xref rid="B63" ref-type="bibr">Xu et al., 2019</xref>). Among <italic>ker-</italic>encoded GT1-GTs, <italic>gtfA</italic>
<sub>
<italic>ker</italic>
</sub>, <italic>gtfB</italic>
<sub>
<italic>ker</italic>
</sub>, and <italic>gtfC</italic>
<sub>
<italic>ker</italic>
</sub> (<italic>ker</italic> was added to distinguish them from <italic>cep</italic> genes) are orthologs of <italic>gtfA</italic>, <italic>gtfB</italic>, and <italic>gtfC</italic>, respectively (<xref rid="B63" ref-type="bibr">Xu et al., 2019</xref>). Thus, GtfB<sub>ker</sub> most likely installs <sc>d-</sc>glucose at AA-4, and <sc>l-</sc>rhamnose is then appended to <sc>d-</sc>glucose by GtfC<sub>ker</sub>; this leaves GtfA<sub>ker</sub> responsible for the attachment of <sc>l-</sc>actinosamine at AA-6 (<xref rid="F2" ref-type="fig">Figure 2B</xref>). Single <italic>ker-</italic>encoded GT39-GT GtfD<sub>ker</sub> most probably attaches <sc>d-</sc>mannose at AA-7 (<xref rid="F2" ref-type="fig">Figure 2B</xref>).</p><p>More information is available on the GTs involved in the biosynthesis of type III dalbaheptides. Ristocetin BGC encodes 6&#x000a0;GTs, four of GT1 family and two belonging to the GT39 family (<xref rid="B58" ref-type="bibr">Truman et al., 2014</xref>). Phylogenetic reconstruction allowed to assign functions to 4 GTs, assuming that Orf16 attaches <sc>l-</sc>ristosamine at AA-6, Orf17&#x02010;<sc>d-</sc>glucose at AA-4, then appended with <sc>d-</sc>mannose by Orf34; finally, a second mannosyltransferase&#x02010;Orf22&#x02010;was expected to act at AA-7 (<xref rid="F2" ref-type="fig">Figure 2C</xref>, <xref rid="B58" ref-type="bibr">Truman et al., 2014</xref>), as later confirmed by its heterologous expression in <italic>Streptomyces coelicolor</italic> carrying <italic>sta</italic> (<xref rid="B67" ref-type="bibr">Yim et al., 2016</xref>)<italic>.</italic> Functions of Orf18 and Orf20 were not assigned, since these proteins were distantly related to known GTs (<xref rid="B58" ref-type="bibr">Truman et al., 2014</xref>). Another type III dalbaheptide&#x02010;UK-68,597&#x02010;is decorated with 2-<sc>L-</sc>vancosaminyl-<sc>d-</sc>glucose disaccharide at AA-4 (<xref rid="B65" ref-type="bibr">Yim et al., 2014a</xref>), while <italic>auk</italic> carries three genes for GT1-GTs. <italic>In vitro</italic> assay showed that Auk10 (GtfB ortholog) is responsible for glucosylation; <italic>in silico</italic> analysis then suggested <sc>l-</sc>vancosamine to be installed by Auk11 (GtfC ortholog, <xref rid="F2" ref-type="fig">Figure 2C</xref>) (<xref rid="B65" ref-type="bibr">Yim et al., 2014a</xref>). Although the third GT, Auk14, is a GtfA ortholog, UK-68,597 lacks sugar residues at AA-6. <italic>In vitro</italic> assay suggested that Auk14 might be inactive or possess a very low affinity to substrates available in UK-68,597 biosynthesis, as observed with BgtfA (<xref rid="B65" ref-type="bibr">Yim et al., 2014a</xref>).</p><p>Glycosylation events that take place in type IV dalbaheptide biosynthesis are well defined (<xref rid="F2" ref-type="fig">Figure 2D</xref>). <italic>tei</italic> and <italic>dbv</italic> BGCs encode three and two GTs, respectively. Accordingly, both antibiotics carry a Glc<italic>N</italic>Ac moiety at AA-4 and <sc>d-</sc>mannose at AA-7, while teicoplanin aglycone is also decorated with another Glc<italic>N</italic>Ac at AA-6. GtfB ortholog&#x02010;Tei10*&#x02010;installs the Glc<italic>N</italic>Ac moiety at AA-4, as demonstrated from multiple <italic>in vivo</italic> and <italic>in vitro</italic> experiments (<xref rid="B29" ref-type="bibr">Li et al., 2004</xref>; <xref rid="B22" ref-type="bibr">Howard-Jones et al., 2007</xref>; <xref rid="B56" ref-type="bibr">Truman et al., 2009</xref>; <xref rid="B70" ref-type="bibr">Yushchuk et al., 2016</xref>, <xref rid="B71" ref-type="bibr">2020b</xref>). Consistently, Dbv9&#x02010;a Tei10* ortholog&#x02010;is supposed to play the same role in A40926 glycosylation. Tei1 was shown to attach Glc<italic>N</italic>Ac to teicoplanin aglycone at AA-6 (<xref rid="B29" ref-type="bibr">Li et al., 2004</xref>), whereas <italic>dbv</italic> lacks any Tei1 ortholog, explaining why A40926 has no sugars at AA-6. Finally, Tei3* was shown to be responsible for the decoration of teicoplanin aglycone with <sc>d-</sc>mannose at AA-7 (<xref rid="B70" ref-type="bibr">Yushchuk et al., 2016</xref>), implying that Dbv20 (Tei3* ortholog) has the same function in A40926 biosynthesis (<xref rid="F2" ref-type="fig">Figure 2D</xref>). Interestingly, ramoplanin BGC (<italic>ramo</italic>), recently shown to be genetically related to <italic>tei</italic> (<xref rid="B61" ref-type="bibr">Waglechner et al., 2019</xref>), encodes a homolog of Tei3*&#x02010;Ramo29 (45% aa s.i., <xref rid="B13" ref-type="bibr">Chen et al., 2013</xref>). Ramoplanin is a clinically relevant peptide antibiotic produced by <italic>Actinoplanes ramoplaninifer</italic> ATCC 33076 (<xref rid="B37" ref-type="bibr">Marcone et al., 2017</xref>). Unlike dalbaheptides, it carries a 4-<sc>d-</sc>mannosyl-<sc>d-</sc>mannose disaccharide, instead of a single <sc>d-</sc>mannose residue. Ramo29 was shown to install the first <sc>d-</sc>mannose residue (<xref rid="B13" ref-type="bibr">Chen et al., 2013</xref>), but the GT responsible for the second mannosylation remains unknown. This merits further investigation, since such GT looks like a promising tool to further modify mannosylated dalbaheptides.</p><p>Concluding this section, it is interesting to report that genes for GTs tend to form one operon in type I-III BGCs (<xref rid="B49" ref-type="bibr">Shawky et al., 2007</xref>; <xref rid="B31" ref-type="bibr">Liu et al., 2021</xref>), being more scattered in type IV BGCs (<xref rid="B1" ref-type="bibr">Alduina et al., 2007</xref>; <xref rid="B69" ref-type="bibr">Yushchuk et al., 2019</xref>). It is also notable that genes for mannosyltransferases are present in different types of BGCs coming from distant actinobacterial lineages. This might indicate <sc>d-</sc>mannose residues at AA-7 to be an ancestral feature for all dalbaheptides.</p></sec><sec id="s1-3"><title>Further Modification Occurring on Attached Sugar Residues</title><p>Some further modifications of attached sugars occur during the biosynthesis of dalbaheptides, although they are quite rare. The first example comes from pekiskomycin, having <sc>d-</sc>glucose methylated. <italic>pek</italic> encodes two methyltransferases. One of them&#x02010;Pek30&#x02010;was experimentally shown to methylate the N-terminus of A47934 aglycone (<xref rid="B67" ref-type="bibr">Yim et al., 2016</xref>), leaving the other&#x02010;Pek16&#x02010;possibly responsible for <sc>d-</sc>glucose methylation (<xref rid="F2" ref-type="fig">Figure 2A</xref>). Another notable modification is the acylation of AA-4 Glc<italic>N</italic>Ac in type IV dalbaheptides, such as teicoplanin and A40926. To achieve this modification, Glc<italic>N</italic>Ac at AA-4 is first deacetylated with orthologous deacetylases Tei2*/Dbv21 (<xref rid="B20" ref-type="bibr">Ho et al., 2006</xref>; <xref rid="B59" ref-type="bibr">Truman et al., 2006</xref>), and <italic>N</italic>-glucosamine is then acylated with orthologous acyltransferases Tei11*/Dbv8 (<xref rid="F2" ref-type="fig">Figure 2D</xref>) (<xref rid="B29" ref-type="bibr">Li et al., 2004</xref>; <xref rid="B27" ref-type="bibr">Kruger et al., 2005</xref>; <xref rid="B22" ref-type="bibr">Howard-Jones et al., 2007</xref>; <xref rid="B70" ref-type="bibr">Yushchuk et al., 2016</xref>). Peculiarly, orthologs of Tei2*/Dbv21 are present in many (if not in all) BGCs for non-acylated type I-III dalbaheptides. The one from <italic>cep</italic>&#x02010;CepI&#x02010;was studied <italic>in vitro</italic> and shown to be inactive due to a single aa substitution (<xref rid="B57" ref-type="bibr">Truman et al., 2008</xref>). The omnipresence of <italic>tei2*</italic> orthologs in type I-III BGCs induces to speculate that the <italic>N-</italic>acylglucosamine moiety at AA-4 is an ancestral feature, lost or modified in many evolutionary lineages of dalbaheptides.</p><p>Modifications of A40926 sugars do not end with acylation. <italic>N</italic>-acylglucosamine moiety is further oxidized to <italic>N</italic>-acylaminoglucuronic acid group by Dbv29 (<xref rid="F2" ref-type="fig">Figure 2D</xref>) (<xref rid="B30" ref-type="bibr">Li et al., 2007</xref>). The biological role of such modification is unclear, although it seems to reduce the A40926 antimicrobial activity (<xref rid="B35" ref-type="bibr">Malabarba et al., 1995</xref>). Peculiarly, <italic>noc</italic> BGC in <italic>N. coxensis</italic> DSM 45129 lacks an ortholog for <italic>dbv29</italic>, coding the biosynthesis of non-oxidized A40926 analog&#x02010;dalbaheptide A50926 (<xref rid="B72" ref-type="bibr">Yushchuk et al., 2021</xref>). Finally, the <sc>d-</sc>mannose residue at AA-7 of A40926 is <italic>O-</italic>acetylated with Dbv23 (<xref rid="F2" ref-type="fig">Figure 2D</xref>) (<xref rid="B51" ref-type="bibr">Sosio et al., 2010</xref>). This modification is unstable and fades away in the alkaline extraction of A40926 (<xref rid="B4" ref-type="bibr">Alt et al., 2019</xref>); once again, its biological role is unclear, although it might be important for the regulation of antibiotic export and self-resistance (<xref rid="B2" ref-type="bibr">Alduina et al., 2020</xref>).</p></sec></sec><sec id="s2"><title>Conclusion and Outlook</title><p>Further research of dalbaheptide glycosylation is important for several reasons. Understanding of GTs donor- (activated sugar) and acceptor- (aglycone) substrate specificities will allow further chemical derivatization of these scaffolds using <italic>in vitro</italic> chemo-enzymatic synthesis (<xref rid="B43" ref-type="bibr">Nakayama et al., 2014</xref>) or <italic>in vivo</italic> combinatorial biosynthesis (<xref rid="B67" ref-type="bibr">Yim et al., 2016</xref>). While the first approach has been widely investigated in the past for generating novel hybrid GPAs by combining natural and synthetic aglycones and sugars (as reviewed in <xref rid="B36" ref-type="bibr">Marcone et al., 2018</xref>), <italic>in vivo</italic> combinatorial biosynthesis is promising, but still rather limited in its applications. Alternatively, the two-domain architecture of GT1-GTs might be exploited to create &#x0201c;chimaeras&#x0201d; with an expanded functional repertoire (<xref rid="B56" ref-type="bibr">Truman et al., 2009</xref>). Finally, a better comprehension of glycosylation mechanisms will contribute to tracing out a more complete picture of dalbaheptide evolution. Unlike other aspects of glycopeptide biosynthesis (<xref rid="B16" ref-type="bibr">Donadio et al., 2005</xref>; <xref rid="B61" ref-type="bibr">Waglechner et al., 2019</xref>; <xref rid="B5" ref-type="bibr">Andreo-Vidal et al., 2021</xref>), phylogenomics of GTs and sugar modification enzymes has not been studied yet. We believe that such reconstruction might open new scenarios on the evolution of antibiotic biosynthetic pathways.</p></sec></body><back><ack><p>We are grateful to Consorzio Interuniversitario per le Biotecnologie for supporting FB congresses attendances.</p></ack><sec id="s3"><title>Author Contributions</title><p>KZ, FB, and OY collected data and articles and co-wrote the review; OY prepared the figures; and VF and FM supervised the work and co-wrote the review.</p></sec><sec id="s4"><title>Funding</title><p>This work was supported by grant &#x0201c;Fondo di Ateneo per la Ricerca&#x0201d; to FM and FB and by the BG-09F grant of the Ministry of Education and Science of Ukraine to VF.</p></sec><sec sec-type="COI-statement" id="s5"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s6"><title>Publisher&#x02019;s Note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alduina</surname><given-names>R.</given-names></name><name><surname>Piccolo</surname><given-names>L. L.</given-names></name><name><surname>D'Alia</surname><given-names>D.</given-names></name><name><surname>Ferraro</surname><given-names>C.</given-names></name><name><surname>Gunnarsson</surname><given-names>N.</given-names></name><name><surname>Donadio</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Phosphate-controlled Regulator for the Biosynthesis of the Dalbavancin Precursor A40926</article-title>. <source>J. Bacteriol.</source>
<volume>189</volume>, <fpage>8120</fpage>&#x02013;<lpage>8129</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01247-07</pub-id>
<pub-id pub-id-type="pmid">17873036</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alduina</surname><given-names>R.</given-names></name><name><surname>Tocchetti</surname><given-names>A.</given-names></name><name><surname>Costa</surname><given-names>S.</given-names></name><name><surname>Ferraro</surname><given-names>C.</given-names></name><name><surname>Cancemi</surname><given-names>P.</given-names></name><name><surname>Sosio</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A Two-Component Regulatory System with Opposite Effects on Glycopeptide Antibiotic Biosynthesis and Resistance</article-title>. <source>Sci. Rep.</source>
<volume>10</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-63257-4</pub-id>
<pub-id pub-id-type="pmid">31913322</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Allen</surname><given-names>N. E.</given-names></name><name><surname>LeTourneau</surname><given-names>D. L.</given-names></name><name><surname>Hobbs</surname><given-names>J. N.</given-names></name><name><surname>Thompson</surname><given-names>R. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Hexapeptide Derivatives of Glycopeptide Antibiotics: Tools for Mechanism of Action Studies</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>46</volume>, <fpage>2344</fpage>&#x02013;<lpage>2348</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.46.8.2344-2348.2002</pub-id>
<pub-id pub-id-type="pmid">12121903</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alt</surname><given-names>S.</given-names></name><name><surname>Bernasconi</surname><given-names>A.</given-names></name><name><surname>Sosio</surname><given-names>M.</given-names></name><name><surname>Brunati</surname><given-names>C.</given-names></name><name><surname>Donadio</surname><given-names>S.</given-names></name><name><surname>Maffioli</surname><given-names>S. I.</given-names></name></person-group> (<year>2019</year>). <article-title>Toward Single-Peak Dalbavancin Analogs through Biology and Chemistry</article-title>. <source>ACS Chem. Biol.</source>
<volume>14</volume>, <fpage>356</fpage>&#x02013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.9b00050</pub-id>
<pub-id pub-id-type="pmid">30830742</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andreo-Vidal</surname><given-names>A.</given-names></name><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Fedorenko</surname><given-names>V.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Yushchuk</surname><given-names>O.</given-names></name></person-group> (<year>2021</year>). <article-title>Genomic Insights into the Distribution and Phylogeny of Glycopeptide Resistance Determinants within the <italic>Actinobacteria</italic> Phylum</article-title>. <source>Antibiotics</source>
<volume>10</volume>, <fpage>1533</fpage>&#x02013;<lpage>1630</lpage>. <pub-id pub-id-type="doi">10.3390/antibiotics10121533</pub-id>
<pub-id pub-id-type="pmid">34943745</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beauregard</surname><given-names>D. A.</given-names></name><name><surname>Williams</surname><given-names>D. H.</given-names></name><name><surname>Gwynn</surname><given-names>M. N.</given-names></name><name><surname>Knowles</surname><given-names>D. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Dimerization and Membrane Anchors in Extracellular Targeting of Vancomycin Group Antibiotics</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>39</volume>, <fpage>781</fpage>&#x02013;<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.39.3.781</pub-id>
<pub-id pub-id-type="pmid">7793894</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>B&#x000e9;rdy</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Bioactive Microbial Metabolites</article-title>. <source>J. Antibiot.</source>
<volume>58</volume>, <fpage>1</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2005.1</pub-id>
</mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Marcone</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Old and New Glycopeptide Antibiotics: Action and Resistance</article-title>. <source>Antibiotics</source>
<volume>3</volume>, <fpage>572</fpage>&#x02013;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.3390/antibiotics3040572</pub-id>
<pub-id pub-id-type="pmid">27025757</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Butler</surname><given-names>M. S.</given-names></name><name><surname>Hansford</surname><given-names>K. A.</given-names></name><name><surname>Blaskovich</surname><given-names>M. A. T.</given-names></name><name><surname>Halai</surname><given-names>R.</given-names></name><name><surname>Cooper</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Glycopeptide Antibiotics: Back to the Future</article-title>. <source>J. Antibiot.</source>
<volume>67</volume>, <fpage>631</fpage>&#x02013;<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2014.111</pub-id>
</mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Butz</surname><given-names>D.</given-names></name><name><surname>Schmiederer</surname><given-names>T.</given-names></name><name><surname>Hadatsch</surname><given-names>B.</given-names></name><name><surname>Wohlleben</surname><given-names>W.</given-names></name><name><surname>Weber</surname><given-names>T.</given-names></name><name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Module Extension of a Non-ribosomal Peptide Synthetase of the Glycopeptide Antibiotic Balhimycin Produced by <italic>Amycolatopsis balhimycina</italic>
</article-title>. <source>ChemBioChem</source>
<volume>9</volume>, <fpage>1195</fpage>&#x02013;<lpage>1200</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.200800068</pub-id>
<pub-id pub-id-type="pmid">18399534</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>A.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Phillips</surname><given-names>G. N.</given-names></name><name><surname>Thorson</surname><given-names>J. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Glycosyltransferase Structural Biology and its Role in the Design of Catalysts for Glycosylation</article-title>. <source>Curr. Opin. Biotechnol.</source>
<volume>22</volume>, <fpage>800</fpage>&#x02013;<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2011.04.013</pub-id>
<pub-id pub-id-type="pmid">21592771</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Thomas</surname><given-names>M. G.</given-names></name><name><surname>Hubbard</surname><given-names>B. K.</given-names></name><name><surname>Losey</surname><given-names>H. C.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name><name><surname>Burkart</surname><given-names>M. D.</given-names></name></person-group> (<year>2000</year>). <article-title>Deoxysugars in Glycopeptide Antibiotics: Enzymatic Synthesis of TDP-L-Epivancosamine in Chloroeremomycin Biosynthesis</article-title>. <source>Proc. Natl. Acad. Sci.</source>
<volume>97</volume>, <fpage>11942</fpage>&#x02013;<lpage>11947</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.210395097</pub-id>
<pub-id pub-id-type="pmid">11035791</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.-S.</given-names></name><name><surname>Wang</surname><given-names>Y.-X.</given-names></name><name><surname>Shao</surname><given-names>L.</given-names></name><name><surname>Pan</surname><given-names>H.-X.</given-names></name><name><surname>Li</surname><given-names>J.-A.</given-names></name><name><surname>Lin</surname><given-names>H.-M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Functional Identification of the Gene Encoding the Enzyme Involved in Mannosylation in Ramoplanin Biosynthesis in <italic>Actinoplanes</italic> Sp</article-title>. <source>Biotechnol. Lett.</source>
<volume>35</volume>, <fpage>1501</fpage>&#x02013;<lpage>1508</lpage>. <pub-id pub-id-type="doi">10.1007/s10529-013-1233-3</pub-id>
<pub-id pub-id-type="pmid">23892980</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coller</surname><given-names>B. S.</given-names></name><name><surname>Gralnick</surname><given-names>H. R.</given-names></name></person-group> (<year>1977</year>). <article-title>Studies on the Mechanism of Ristocetin-Induced Platelet Agglutination</article-title>. <source>J. Clin. Invest.</source>
<volume>60</volume>, <fpage>302</fpage>&#x02013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1172/JCI108778</pub-id>
<pub-id pub-id-type="pmid">17620</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Crotty</surname><given-names>M. P.</given-names></name><name><surname>Krekel</surname><given-names>T.</given-names></name><name><surname>Burnham</surname><given-names>C.-A. D.</given-names></name><name><surname>Ritchie</surname><given-names>D. J.</given-names></name></person-group> (<year>2016</year>). <article-title>New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides</article-title>. <source>J. Clin. Microbiol.</source>
<volume>54</volume>, <fpage>2225</fpage>&#x02013;<lpage>2232</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.03395-15</pub-id>
<pub-id pub-id-type="pmid">26962092</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Donadio</surname><given-names>S.</given-names></name><name><surname>Sosio</surname><given-names>M.</given-names></name><name><surname>Stegmann</surname><given-names>E.</given-names></name><name><surname>Weber</surname><given-names>T.</given-names></name><name><surname>Wohlleben</surname><given-names>W.</given-names></name></person-group> (<year>2005</year>). <article-title>Comparative Analysis and Insights into the Evolution of Gene Clusters for Glycopeptide Antibiotic Biosynthesis</article-title>. <source>Mol. Genet. Genomics</source>
<volume>274</volume>, <fpage>40</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s00438-005-1156-3</pub-id>
<pub-id pub-id-type="pmid">16007453</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drula</surname><given-names>E.</given-names></name><name><surname>Garron</surname><given-names>M.-L.</given-names></name><name><surname>Dogan</surname><given-names>S.</given-names></name><name><surname>Lombard</surname><given-names>V.</given-names></name><name><surname>Henrissat</surname><given-names>B.</given-names></name><name><surname>Terrapon</surname><given-names>N.</given-names></name></person-group> (<year>2022</year>). <article-title>The Carbohydrate-Active Enzyme Database: Functions and Literature</article-title>. <source>Nucleic Acids Res.</source>
<volume>50</volume>, <fpage>D571</fpage>&#x02013;<lpage>D577</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab1045</pub-id>
<pub-id pub-id-type="pmid">34850161</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gangarosa</surname><given-names>E. J.</given-names></name><name><surname>Landerman</surname><given-names>N. S.</given-names></name><name><surname>Rosch</surname><given-names>P. J.</given-names></name><name><surname>Herndon</surname><given-names>E. G.</given-names></name></person-group> (<year>1958</year>). <article-title>Hematologic Complications Arising during Ristocetin Therapy</article-title>. <source>N. Engl. J. Med.</source>
<volume>259</volume>, <fpage>156</fpage>&#x02013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1056/nejm195807242590402</pub-id>
<pub-id pub-id-type="pmid">13566439</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerhard</surname><given-names>U.</given-names></name><name><surname>Mackay</surname><given-names>J. P.</given-names></name><name><surname>Maplestone</surname><given-names>R. A.</given-names></name><name><surname>Williams</surname><given-names>D. H.</given-names></name></person-group> (<year>1993</year>). <article-title>The Role of the Sugar and Chlorine Substituents in the Dimerization of Vancomycin Antibiotics</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>115</volume>, <fpage>232</fpage>&#x02013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1021/ja00054a033</pub-id>
</mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ho</surname><given-names>J.-Y.</given-names></name><name><surname>Huang</surname><given-names>Y.-T.</given-names></name><name><surname>Wu</surname><given-names>C.-J.</given-names></name><name><surname>Li</surname><given-names>Y.-S.</given-names></name><name><surname>Tsai</surname><given-names>M.-D.</given-names></name><name><surname>Li</surname><given-names>T.-L.</given-names></name></person-group> (<year>2006</year>). <article-title>Glycopeptide Biosynthesis: Dbv21/Orf2* from <italic>dbv/tcp</italic> Gene Clusters Are <italic>N</italic>-Ac-Glm Teicoplanin Pseudoaglycone Deacetylases and Orf15 from <italic>cep</italic> Gene Cluster Is a Glc-1-P Thymidyltransferase</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>128</volume>, <fpage>13694</fpage>&#x02013;<lpage>13695</lpage>. <pub-id pub-id-type="doi">10.1021/ja0644834</pub-id>
<pub-id pub-id-type="pmid">17044690</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howard</surname><given-names>M. A.</given-names></name><name><surname>Firkin</surname><given-names>B. G.</given-names></name></person-group> (<year>1971</year>). <article-title>Ristocetin - A New Tool in the Investigation of Platelet Aggregation</article-title>. <source>Thromb. Haemost.</source>
<volume>26</volume>, <fpage>362</fpage>&#x02013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1055/s-0038-1653684</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howard-Jones</surname><given-names>A. R.</given-names></name><name><surname>Kruger</surname><given-names>R. G.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Tao</surname><given-names>J.</given-names></name><name><surname>Leimkuhler</surname><given-names>C.</given-names></name><name><surname>Kahne</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Kinetic Analysis of Teicoplanin Glycosyltransferases and Acyltransferase Reveal Ordered Tailoring of Aglycone Scaffold to Reconstitute Mature Teicoplanin</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>129</volume>, <fpage>10082</fpage>&#x02013;<lpage>10083</lpage>. <pub-id pub-id-type="doi">10.1021/ja0735857</pub-id>
<pub-id pub-id-type="pmid">17661468</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hutchings</surname><given-names>M. I.</given-names></name><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Wilkinson</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Antibiotics: Past, Present and Future</article-title>. <source>Curr. Opin. Microbiol.</source>
<volume>51</volume>, <fpage>72</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2019.10.008</pub-id>
<pub-id pub-id-type="pmid">31733401</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jovetic</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Marcone</surname><given-names>G. L.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Tramper</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>&#x003b2;-Lactam and Glycopeptide Antibiotics: First and Last Line of Defense?</article-title>
<source>Trends Biotechnol.</source>
<volume>28</volume>, <fpage>596</fpage>&#x02013;<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2010.09.004</pub-id>
<pub-id pub-id-type="pmid">20970210</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirkpatrick</surname><given-names>P. N.</given-names></name><name><surname>Scaife</surname><given-names>W.</given-names></name><name><surname>Spencer</surname><given-names>J. B.</given-names></name><name><surname>Williams</surname><given-names>D. H.</given-names></name><name><surname>Hallis</surname><given-names>T. M.</given-names></name><name><surname>Liu</surname><given-names>H.-w.</given-names></name></person-group> (<year>2000</year>). <article-title>Characterisation of a Sugar Epimerase Enzyme Involved in the Biosynthesis of a Vancomycin-Group Antibiotic</article-title>. <source>Chem. Commun.</source>
<volume>17</volume>, <fpage>1565</fpage>&#x02013;<lpage>1566</lpage>. <pub-id pub-id-type="doi">10.1039/b004463f</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klinker</surname><given-names>K. P.</given-names></name><name><surname>Borgert</surname><given-names>S. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Beyond Vancomycin: the Tail of the Lipoglycopeptides</article-title>. <source>Clin. Ther.</source>
<volume>37</volume>, <fpage>2619</fpage>&#x02013;<lpage>2636</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinthera.2015.11.007</pub-id>
<pub-id pub-id-type="pmid">26658277</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kruger</surname><given-names>R. G.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Oberth&#x000fc;r</surname><given-names>M.</given-names></name><name><surname>Tao</surname><given-names>J.</given-names></name><name><surname>Kahne</surname><given-names>D.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name></person-group> (<year>2005</year>). <article-title>Tailoring of Glycopeptide Scaffolds by the Acyltransferases from the Teicoplanin and A-40,926 Biosynthetic Operons</article-title>. <source>Chem. Biol.</source>
<volume>12</volume>, <fpage>131</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2004.12.005</pub-id>
<pub-id pub-id-type="pmid">15664522</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lairson</surname><given-names>L. L.</given-names></name><name><surname>Henrissat</surname><given-names>B.</given-names></name><name><surname>Davies</surname><given-names>G. J.</given-names></name><name><surname>Withers</surname><given-names>S. G.</given-names></name></person-group> (<year>2008</year>). <article-title>Glycosyltransferases: Structures, Functions, and Mechanisms</article-title>. <source>Annu. Rev. Biochem.</source>
<volume>77</volume>, <fpage>521</fpage>&#x02013;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.76.061005.092322</pub-id>
<pub-id pub-id-type="pmid">18518825</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Haydock</surname><given-names>S.</given-names></name><name><surname>Mironenko</surname><given-names>T.</given-names></name><name><surname>Leadlay</surname><given-names>P.</given-names></name><name><surname>Spencer</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Biosynthetic Gene Cluster of the Glycopeptide Antibiotic Teicoplanin Characterization of Two Glycosyltransferases and the Key Acyltransferase</article-title>. <source>Chem. Biol.</source>
<volume>11</volume>, <fpage>107</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(04)00002-X</pub-id>
<pub-id pub-id-type="pmid">15113000</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.-S.</given-names></name><name><surname>Ho</surname><given-names>J.-Y.</given-names></name><name><surname>Huang</surname><given-names>C.-C.</given-names></name><name><surname>Lyu</surname><given-names>S.-Y.</given-names></name><name><surname>Lee</surname><given-names>C.-Y.</given-names></name><name><surname>Huang</surname><given-names>Y.-T.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>A Unique Flavin Mononucleotide-Linked Primary Alcohol Oxidase for Glycopeptide A40926 Maturation</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>129</volume>, <fpage>13384</fpage>&#x02013;<lpage>13385</lpage>. <pub-id pub-id-type="doi">10.1021/ja075748x</pub-id>
<pub-id pub-id-type="pmid">17935335</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Hu</surname><given-names>X.-R.</given-names></name><name><surname>Zhao</surname><given-names>L.-X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>Tao</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Enhancing Ristomycin A Production by Overexpression of ParB-like StrR Family Regulators Controlling the Biosynthesis Genes</article-title>. <source>Appl. Environ. Microbiol.</source>
<volume>87</volume>, <fpage>1</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.01066-21</pub-id>
</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Losey</surname><given-names>H. C.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Biggins</surname><given-names>J. B.</given-names></name><name><surname>Oberth&#x000fc;r</surname><given-names>M.</given-names></name><name><surname>Ye</surname><given-names>X.-Y.</given-names></name><name><surname>Dong</surname><given-names>S. D.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Incorporation of Glucose Analogs by GtfE and GtfD from the Vancomycin Biosynthetic Pathway to Generate Variant Glycopeptides</article-title>. <source>Chem. Biol.</source>
<volume>9</volume>, <fpage>1305</fpage>&#x02013;<lpage>1314</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(02)00270-3</pub-id>
<pub-id pub-id-type="pmid">12498883</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Losey</surname><given-names>H. C.</given-names></name><name><surname>Peczuh</surname><given-names>M. W.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Eggert</surname><given-names>U. S.</given-names></name><name><surname>Dong</surname><given-names>S. D.</given-names></name><name><surname>Pelczer</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Tandem Action of Glycosyltransferases in the Maturation of Vancomycin and Teicoplanin Aglycones: Novel Glycopeptides,</article-title>. <source>Biochemistry</source>
<volume>40</volume>, <fpage>4745</fpage>&#x02013;<lpage>4755</lpage>. <pub-id pub-id-type="doi">10.1021/bi010050w</pub-id>
<pub-id pub-id-type="pmid">11294642</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mackay</surname><given-names>J. P.</given-names></name><name><surname>Gerhard</surname><given-names>U.</given-names></name><name><surname>Beauregard</surname><given-names>D. A.</given-names></name><name><surname>Maplestone</surname><given-names>R. A.</given-names></name><name><surname>Williams</surname><given-names>D. H.</given-names></name></person-group> (<year>1994</year>). <article-title>Dissection of the Contributions toward Dimerization of Glycopeptide Antibiotics</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>116</volume>, <fpage>4573</fpage>&#x02013;<lpage>4580</lpage>. <pub-id pub-id-type="doi">10.1021/ja00090a005</pub-id>
</mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Malabarba</surname><given-names>A.</given-names></name><name><surname>Ciabatti</surname><given-names>R.</given-names></name><name><surname>Scotti</surname><given-names>R.</given-names></name><name><surname>Goldstein</surname><given-names>B. P.</given-names></name><name><surname>Ferrari</surname><given-names>P.</given-names></name><name><surname>Kurz</surname><given-names>M.</given-names></name><etal/></person-group> (<year>1995</year>). <article-title>New Semisynthetic Glycopeptides MDL 63,246 and MDL 63,042, and Other Amide Derivatives of Antibiotic A-40,926 Active against Highly Glycopeptide-Resistant VanA Enterococci</article-title>. <source>J. Antibiot.</source>
<volume>48</volume>, <fpage>869</fpage>&#x02013;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.48.869</pub-id>
</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marcone</surname><given-names>G. L.</given-names></name><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Berini</surname><given-names>F.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Old and New Glycopeptide Antibiotics: from Product to Gene and Back in the post-genomic Era</article-title>. <source>Biotechnol. Adv.</source>
<volume>36</volume>, <fpage>534</fpage>&#x02013;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.02.009</pub-id>
<pub-id pub-id-type="pmid">29454983</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marcone</surname><given-names>G. L.</given-names></name><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Reguzzoni</surname><given-names>M.</given-names></name><name><surname>Gastaldo</surname><given-names>L.</given-names></name><name><surname>Dalmastri</surname><given-names>C.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Classification of <italic>Actinoplanes</italic> Sp. ATCC 33076, an Actinomycete that Produces the Glycolipodepsipeptide Antibiotic Ramoplanin, as <italic>Actinoplanes ramoplaninifer</italic> Sp. Nov</article-title>. <source>Int. J. Syst. Evol. Microbiol.</source>
<volume>67</volume>, <fpage>4181</fpage>&#x02013;<lpage>4188</lpage>. <pub-id pub-id-type="doi">10.1099/ijsem.0.002281</pub-id>
<pub-id pub-id-type="pmid">28905706</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Medema</surname><given-names>M. H.</given-names></name><name><surname>Kottmann</surname><given-names>R.</given-names></name><name><surname>Yilmaz</surname><given-names>P.</given-names></name><name><surname>Cummings</surname><given-names>M.</given-names></name><name><surname>Biggins</surname><given-names>J. B.</given-names></name><name><surname>Blin</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Minimum Information about a Biosynthetic Gene Cluster</article-title>. <source>Nat. Chem. Biol.</source>
<volume>11</volume>, <fpage>625</fpage>&#x02013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1890</pub-id>
<pub-id pub-id-type="pmid">26284661</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Medema</surname><given-names>M. H.</given-names></name><name><surname>Cimermancic</surname><given-names>P.</given-names></name><name><surname>Sali</surname><given-names>A.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name><name><surname>Fischbach</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>A Systematic Computational Analysis of Biosynthetic Gene Cluster Evolution: Lessons for Engineering Biosynthesis</article-title>. <source>Plos Comput. Biol.</source>
<volume>10</volume>, <fpage>e1004016</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1004016</pub-id>
<pub-id pub-id-type="pmid">25474254</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mulichak</surname><given-names>A. M.</given-names></name><name><surname>Losey</surname><given-names>H. C.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name><name><surname>Garavito</surname><given-names>R. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Structure of the UDP-Glucosyltransferase GtfB that Modifies the Heptapeptide Aglycone in the Biosynthesis of Vancomycin Group Antibiotics</article-title>. <source>Structure</source>
<volume>9</volume>, <fpage>547</fpage>&#x02013;<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-2126(01)00616-5</pub-id>
<pub-id pub-id-type="pmid">11470430</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mulichak</surname><given-names>A. M.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Losey</surname><given-names>H. C.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name><name><surname>Garavito</surname><given-names>R. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Crystal Structure of Vancosaminyltransferase GtfD from the Vancomycin Biosynthetic Pathway: Interactions with Acceptor and Nucleotide Ligands,</article-title>. <source>Biochemistry</source>
<volume>43</volume>, <fpage>5170</fpage>&#x02013;<lpage>5180</lpage>. <pub-id pub-id-type="doi">10.1021/bi036130c</pub-id>
<pub-id pub-id-type="pmid">15122882</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagarajan</surname><given-names>R.</given-names></name></person-group> (<year>1993</year>). <article-title>Structure-activity Relationships of Vancomycin-type Glycopeptide Antibiotics</article-title>. <source>J. Antibiot.</source>
<volume>46</volume>, <fpage>1181</fpage>&#x02013;<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.46.1181</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>A.</given-names></name><name><surname>Okano</surname><given-names>A.</given-names></name><name><surname>Feng</surname><given-names>Y.</given-names></name><name><surname>Collins</surname><given-names>J. C.</given-names></name><name><surname>Collins</surname><given-names>K. C.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Enzymatic Glycosylation of Vancomycin Aglycon: Completion of a Total Synthesis of Vancomycin and N- and C-Terminus Substituent Effects of the Aglycon Substrate</article-title>. <source>Org. Lett.</source>
<volume>16</volume>, <fpage>3572</fpage>&#x02013;<lpage>3575</lpage>. <pub-id pub-id-type="doi">10.1021/OL501568T/SUPPL_FILE/OL501568T_SI_001.PDF</pub-id>
<pub-id pub-id-type="pmid">24954524</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nicolaou</surname><given-names>K. C.</given-names></name><name><surname>Boddy</surname><given-names>C. N. C.</given-names></name><name><surname>Br&#x000e4;se</surname><given-names>S.</given-names></name><name><surname>Winssinger</surname><given-names>N.</given-names></name></person-group> (<year>1999</year>). <article-title>Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics</article-title>. <source>Angew. Chem. Int. Ed.</source>
<volume>38</volume>, <fpage>2096</fpage>&#x02013;<lpage>2152</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1521-3773(19990802)38:15&#x0003c;2096::aid-anie2096&#x0003e;3.0.co;2-f</pub-id>
</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parenti</surname><given-names>F.</given-names></name><name><surname>Cavalleri</surname><given-names>B.</given-names></name></person-group> (<year>1989</year>). <article-title>Proposal to Name the Vancomycin-Ristocetin like Glycopeptides as Dalbaheptides</article-title>. <source>J. Antibiot.</source>
<volume>42</volume>, <fpage>1882</fpage>&#x02013;<lpage>1883</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.42.1882</pub-id>
</mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pelzer</surname><given-names>S.</given-names></name><name><surname>S&#x000fc;&#x000df;muth</surname><given-names>R.</given-names></name><name><surname>Heckmann</surname><given-names>D.</given-names></name><name><surname>Recktenwald</surname><given-names>J.</given-names></name><name><surname>Huber</surname><given-names>P.</given-names></name><name><surname>Jung</surname><given-names>G.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Identification and Analysis of the Balhimycin Biosynthetic Gene Cluster and its Use for Manipulating Glycopeptide Biosynthesis in <italic>Amycolatopsis mediterranei</italic> DSM5908</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>43</volume>, <fpage>1565</fpage>&#x02013;<lpage>1573</lpage>. <pub-id pub-id-type="doi">10.1128/aac.43.7.1565</pub-id>
<pub-id pub-id-type="pmid">10390204</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pootoolal</surname><given-names>J.</given-names></name><name><surname>Thomas</surname><given-names>M. G.</given-names></name><name><surname>Marshall</surname><given-names>C. G.</given-names></name><name><surname>Neu</surname><given-names>J. M.</given-names></name><name><surname>Hubbard</surname><given-names>B. K.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Assembling the Glycopeptide Antibiotic Scaffold: The Biosynthesis of from <italic>Streptomyces toyocaensis</italic> NRRL15009</article-title>. <source>Proc. Natl. Acad. Sci.</source>
<volume>99</volume>, <fpage>8962</fpage>&#x02013;<lpage>8967</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.102285099</pub-id>
<pub-id pub-id-type="pmid">12060705</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salas</surname><given-names>J. A.</given-names></name><name><surname>M&#x000e9;ndez</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Engineering the Glycosylation of Natural Products in Actinomycetes</article-title>. <source>Trends Microbiol.</source>
<volume>15</volume>, <fpage>219</fpage>&#x02013;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2007.03.004</pub-id>
<pub-id pub-id-type="pmid">17412593</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shawky</surname><given-names>R. M.</given-names></name><name><surname>Puk</surname><given-names>O.</given-names></name><name><surname>Wietzorrek</surname><given-names>A.</given-names></name><name><surname>Pelzer</surname><given-names>S.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name><name><surname>Wohlleben</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>The Border Sequence of the Balhimycin Biosynthesis Gene Cluster from <italic>Amycolatopsis balhimycina</italic> Contains <italic>bbr</italic>, Encoding a StrR-like Pathway-specific Regulator</article-title>. <source>J. Mol. Microbiol. Biotechnol.</source>
<volume>13</volume>, <fpage>76</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1159/000103599</pub-id>
<pub-id pub-id-type="pmid">17693715</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Snyder</surname><given-names>N. J.</given-names></name><name><surname>Cooper</surname><given-names>R. D. G.</given-names></name><name><surname>Briggs</surname><given-names>B. S.</given-names></name><name><surname>Zmijewski</surname><given-names>M.</given-names></name><name><surname>Mullen</surname><given-names>D. L.</given-names></name><name><surname>Kaiser</surname><given-names>R. E.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Enzymatic Deacylation of Teicoplanin Followed by Reductive Alkylation: Synthesis and Antibacterial Activity of New Glycopeptides</article-title>. <source>J. Antibiot.</source>
<volume>51</volume>, <fpage>945</fpage>&#x02013;<lpage>951</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.51.945</pub-id>
</mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sosio</surname><given-names>M.</given-names></name><name><surname>Canavesi</surname><given-names>A.</given-names></name><name><surname>Stinchi</surname><given-names>S.</given-names></name><name><surname>Donadio</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Improved Production of A40926 by <italic>Nonomuraea</italic> Sp. Through Deletion of a Pathway-specific Acetyltransferase</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>87</volume>, <fpage>1633</fpage>&#x02013;<lpage>1638</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-010-2579-2</pub-id>
<pub-id pub-id-type="pmid">20414653</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sosio</surname><given-names>M.</given-names></name><name><surname>Stinchi</surname><given-names>S.</given-names></name><name><surname>Beltrametti</surname><given-names>F.</given-names></name><name><surname>Lazzarini</surname><given-names>A.</given-names></name><name><surname>Donadio</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>The Gene Cluster for the Biosynthesis of the Glycopeptide Antibiotic A40926 by <italic>Nonomuraea</italic> Species</article-title>. <source>Chem. Biol.</source>
<volume>10</volume>, <fpage>541</fpage>&#x02013;<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(03)00120-0</pub-id>
<pub-id pub-id-type="pmid">12837387</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spohn</surname><given-names>M.</given-names></name><name><surname>Kirchner</surname><given-names>N.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Jochim</surname><given-names>A.</given-names></name><name><surname>Wolf</surname><given-names>F.</given-names></name><name><surname>Muenzer</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Overproduction of Ristomycin a by Activation of a Silent Gene Cluster in <italic>Amycolatopsis japonicum</italic> MG417-CF17</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>58</volume>, <fpage>6185</fpage>&#x02013;<lpage>6196</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.03512-14</pub-id>
<pub-id pub-id-type="pmid">25114137</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>E.</given-names></name><name><surname>Frasch</surname><given-names>H.-J.</given-names></name><name><surname>Wohlleben</surname><given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>Glycopeptide Biosynthesis in the Context of Basic Cellular Functions</article-title>. <source>Curr. Opin. Microbiol.</source>
<volume>13</volume>, <fpage>595</fpage>&#x02013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2010.08.011</pub-id>
<pub-id pub-id-type="pmid">20920883</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thaker</surname><given-names>M. N.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Spanogiannopoulos</surname><given-names>P.</given-names></name><name><surname>Waglechner</surname><given-names>N.</given-names></name><name><surname>King</surname><given-names>A. M.</given-names></name><name><surname>Medina</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Identifying Producers of Antibacterial Compounds by Screening for Antibiotic Resistance</article-title>. <source>Nat. Biotechnol.</source>
<volume>31</volume>, <fpage>922</fpage>&#x02013;<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2685</pub-id>
<pub-id pub-id-type="pmid">24056948</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Dias</surname><given-names>M. V. B.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Blundell</surname><given-names>T. L.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Spencer</surname><given-names>J. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Chimeric Glycosyltransferases for the Generation of Hybrid Glycopeptides</article-title>. <source>Chem. Biol.</source>
<volume>16</volume>, <fpage>676</fpage>&#x02013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2009.04.013</pub-id>
<pub-id pub-id-type="pmid">19549605</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Fan</surname><given-names>Q.</given-names></name><name><surname>R&#x000f6;ttgen</surname><given-names>M.</given-names></name><name><surname>Stegmann</surname><given-names>E.</given-names></name><name><surname>Leadlay</surname><given-names>P. F.</given-names></name><name><surname>Spencer</surname><given-names>J. B.</given-names></name></person-group> (<year>2008</year>). <article-title>The Role of Cep15 in the Biosynthesis of Chloroeremomycin: Reactivation of an Ancestral Catalytic Function</article-title>. <source>Chem. Biol.</source>
<volume>15</volume>, <fpage>476</fpage>&#x02013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2008.03.019</pub-id>
<pub-id pub-id-type="pmid">18482700</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Kwun</surname><given-names>M. J.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>S. H.</given-names></name><name><surname>Suh</surname><given-names>J.-W.</given-names></name><name><surname>Hong</surname><given-names>H.-J.</given-names></name></person-group> (<year>2014</year>). <article-title>Antibiotic Resistance Mechanisms Inform Discovery: Identification and Characterization of a Novel <italic>Amycolatopsis</italic> Strain Producing Ristocetin</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>58</volume>, <fpage>5687</fpage>&#x02013;<lpage>5695</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.03349-14</pub-id>
<pub-id pub-id-type="pmid">25022591</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Robinson</surname><given-names>L.</given-names></name><name><surname>Spencer</surname><given-names>J. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of a Deacetylase Involved in the Maturation of Teicoplanin</article-title>. <source>ChemBioChem</source>
<volume>7</volume>, <fpage>1670</fpage>&#x02013;<lpage>1675</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.200600308</pub-id>
<pub-id pub-id-type="pmid">17009278</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Van Wageningen</surname><given-names>A. A.</given-names></name><name><surname>Kirkpatrick</surname><given-names>P. N.</given-names></name><name><surname>Williams</surname><given-names>D. H.</given-names></name><name><surname>Harris</surname><given-names>B. R.</given-names></name><name><surname>Kershaw</surname><given-names>J. K.</given-names></name><name><surname>Lennard</surname><given-names>N. J.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Sequencing and Analysis of Genes Involved in the Biosynthesis of a Vancomycin Group Antibiotic</article-title>. <source>Chem. Biol.</source>
<volume>5</volume>, <fpage>155</fpage>&#x02013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(98)90060-6</pub-id>
<pub-id pub-id-type="pmid">9545426</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Waglechner</surname><given-names>N.</given-names></name><name><surname>McArthur</surname><given-names>A. G.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name></person-group> (<year>2019</year>). <article-title>Phylogenetic Reconciliation Reveals the Natural History of Glycopeptide Antibiotic Biosynthesis and Resistance</article-title>. <source>Nat. Microbiol.</source>
<volume>4</volume>, <fpage>1862</fpage>&#x02013;<lpage>1871</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-019-0531-5</pub-id>
<pub-id pub-id-type="pmid">31406334</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weist</surname><given-names>S.</given-names></name><name><surname>Kittel</surname><given-names>C.</given-names></name><name><surname>Bischoff</surname><given-names>D.</given-names></name><name><surname>Bister</surname><given-names>B.</given-names></name><name><surname>Pfeifer</surname><given-names>V.</given-names></name><name><surname>Nicholson</surname><given-names>G. J.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Mutasynthesis of Glycopeptide Antibiotics: Variations of Vancomycin's AB-Ring Amino Acid 3,5-Dihydroxyphenylglycine</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>126</volume>, <fpage>5942</fpage>&#x02013;<lpage>5943</lpage>. <pub-id pub-id-type="doi">10.1021/ja0499389</pub-id>
<pub-id pub-id-type="pmid">15137740</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><name><surname>Davis</surname><given-names>K. M.</given-names></name><name><surname>Moon</surname><given-names>K.</given-names></name><name><surname>Bushin</surname><given-names>L. B.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>A Genetics-free Method for High-Throughput Discovery of Cryptic Microbial Metabolites</article-title>. <source>Nat. Chem. Biol.</source>
<volume>15</volume>, <fpage>161</fpage>&#x02013;<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-018-0193-2</pub-id>
<pub-id pub-id-type="pmid">30617293</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Zhong</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Yuan</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Complete Genome Sequence and Comparative Genomic Analyses of the Vancomycin-Producing <italic>Amycolatopsis orientalis</italic>
</article-title>. <source>BMC Genomics</source>
<volume>15</volume>, <fpage>1</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-15-363</pub-id>
<pub-id pub-id-type="pmid">24382143</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yim</surname><given-names>G.</given-names></name><name><surname>Kalan</surname><given-names>L.</given-names></name><name><surname>Koteva</surname><given-names>K.</given-names></name><name><surname>Thaker</surname><given-names>M. N.</given-names></name><name><surname>Waglechner</surname><given-names>N.</given-names></name><name><surname>Tang</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2014a</year>). <article-title>Harnessing the Synthetic Capabilities of Glycopeptide Antibiotic Tailoring Enzymes: Characterization of the UK-68,597 Biosynthetic Cluster</article-title>. <source>ChemBioChem</source>
<volume>15</volume>, <fpage>2613</fpage>&#x02013;<lpage>2623</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201402179</pub-id>
<pub-id pub-id-type="pmid">25255985</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yim</surname><given-names>G.</given-names></name><name><surname>Thaker</surname><given-names>M. N.</given-names></name><name><surname>Koteva</surname><given-names>K.</given-names></name><name><surname>Wright</surname><given-names>G.</given-names></name></person-group> (<year>2014b</year>). <article-title>Glycopeptide Antibiotic Biosynthesis</article-title>. <source>J. Antibiot.</source>
<volume>67</volume>, <fpage>31</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2013.117</pub-id>
</mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yim</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Thaker</surname><given-names>M. N.</given-names></name><name><surname>Tan</surname><given-names>S.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name></person-group> (<year>2016</year>). <article-title>How to Make a Glycopeptide: a Synthetic Biology Approach to Expand Antibiotic Chemical Diversity</article-title>. <source>ACS Infect. Dis.</source>
<volume>2</volume>, <fpage>642</fpage>&#x02013;<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.6b00105</pub-id>
<pub-id pub-id-type="pmid">27759388</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O.</given-names></name><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name></person-group> (<year>2020a</year>). <article-title>Glycopeptide Antibiotic Resistance Genes: Distribution and Function in the Producer Actinomycetes</article-title>. <source>Front. Microbiol.</source>
<volume>11</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2020.01173</pub-id>
<pub-id pub-id-type="pmid">32082274</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O.</given-names></name><name><surname>Horbal</surname><given-names>L.</given-names></name><name><surname>Ostash</surname><given-names>B.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Wohlleben</surname><given-names>W.</given-names></name><name><surname>Stegmann</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Regulation of Teicoplanin Biosynthesis: Refining the Roles of Tei Cluster-Situated Regulatory Genes</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>103</volume>, <fpage>4089</fpage>&#x02013;<lpage>4102</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-019-09789-w</pub-id>
<pub-id pub-id-type="pmid">30937499</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O.</given-names></name><name><surname>Ostash</surname><given-names>B.</given-names></name><name><surname>Pham</surname><given-names>T. H.</given-names></name><name><surname>Luzhetskyy</surname><given-names>A.</given-names></name><name><surname>Fedorenko</surname><given-names>V.</given-names></name><name><surname>Truman</surname><given-names>A. W.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Characterization of the post-assembly Line Tailoring Processes in Teicoplanin Biosynthesis</article-title>. <source>ACS Chem. Biol.</source>
<volume>11</volume>, <fpage>2254</fpage>&#x02013;<lpage>2264</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.6b00018</pub-id>
<pub-id pub-id-type="pmid">27285718</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O.</given-names></name><name><surname>Ostash</surname><given-names>B.</given-names></name><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Fedorenko</surname><given-names>V.</given-names></name></person-group> (<year>2020b</year>). <article-title>Teicoplanin Biosynthesis: Unraveling the Interplay of Structural, Regulatory, and Resistance Genes</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>104</volume>, <fpage>3279</fpage>&#x02013;<lpage>3291</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-020-10436-y</pub-id>
<pub-id pub-id-type="pmid">32076781</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O.</given-names></name><name><surname>Vior</surname><given-names>N. M.</given-names></name><name><surname>Andreo-Vidal</surname><given-names>A.</given-names></name><name><surname>Berini</surname><given-names>F.</given-names></name><name><surname>R&#x000fc;ckert</surname><given-names>C.</given-names></name><name><surname>Busche</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2021</year>). <article-title>Genomic-led Discovery of a Novel Glycopeptide Antibiotic by <italic>Nonomuraea coxensis</italic> DSM 45129</article-title>. <source>ACS Chem. Biol.</source>
<volume>16</volume>, <fpage>915</fpage>&#x02013;<lpage>928</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.1c00170</pub-id>
<pub-id pub-id-type="pmid">33913701</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name></person-group> (<year>2020</year>). <article-title>Glycosyltransferase GT1 Family: Phylogenetic Distribution, Substrates Coverage, and Representative Structural Features</article-title>. <source>Comput. Struct. Biotechnol. J.</source>
<volume>18</volume>, <fpage>1383</fpage>&#x02013;<lpage>1390</lpage>. <pub-id pub-id-type="doi">10.1016/j.csbj.2020.06.003</pub-id>
<pub-id pub-id-type="pmid">32637037</pub-id></mixed-citation></ref></ref-list></back></article>